Drug Trial Radar · NCT02018757
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Last checked: Nov 20, 2026Latest source record: May 28, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
250
Planned (sponsor's estimate)
Start
Jan 2014
Primary completion
Dec 2015
Sponsor
- Lead sponsor
- First Hospital of China Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sun Yat-sen University; Zhongda Hospital; Fudan University; Xijing Hospital
- First posted
- Dec 23, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine whether transarterial chemoembolization containing arsenic trioxide is safe and effective in the treatment of intermediate-stage hepatocellular carcinoma.
Conditions
- Carcinoma, Hepatocellular
Interventions
TACE containing As2O3Drug
transarterial chemoembolization containing a mixture of 20mg of arsenic trioxide, 40mg of adriamycin and some dose of 40% ultra-fluid lipiodol
TACE containing placeboDrug
transarterial chemoembolization containing a mixture of 20mg of placebo, 40mg of adriamycin and some dose of 40% ultra-fluid lipiodol
Primary outcomes
What the sponsor says the trial is designed to measure.
- time to progressionTime frame: From date of randomization until the date of first documented progression, up to 24 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Zhongshan Hospital Fudan University
Shanghai, China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Zhongda Hospital Southeast University
Nanjing, Jiangsu, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
Xijing Hospital,Fourth Military Medical University
Xi'an, Shaanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.